A study from Illinois found that severe COVID-19 may shrink tumors. It could be a new cancer treatment.
The study found that SARS-CoV-2 RNA activates an immune response. It creates unique immune cells called “inducible nonclassical monocytes” (I-NCMs).
These cells possess the remarkable ability to infiltrate both blood vessels and tumours, directly attacking cancer cells and reducing tumour size. The research suggests that I-NCMs may be effective against various cancers. These include melanoma, lung, breast, and bowel cancers.
While the findings are promising, it’s important to note that the study has primarily been conducted on animals. Scientists are hopeful.
They want clinical trials to test this approach for treating advanced, resistant cancers. This adds to research on new ways to fight cancer. It includes using pathogens like salmonella to combat bowel cancer.
Regular cancer screenings remain crucial for early detection and treatment success. As research evolves, these new methods may someday enhance cancer treatments. They could offer new hope to patients worldwide.
